A Systematic Review of Adherence to Cardiovascular Medications in Resource-Limited Settings
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
Medications are a cornerstone of the prevention and management of cardiovascular disease. Long-term medication adherence has been the subject of increasing attention in the developed world but has received little attention in resource-limited settings, where the burden of disease is particularly high and growing rapidly. To evaluate prevalence and predictors of non-adherence to cardiovascular medications in this context, we systematically reviewed the peer-reviewed literature.
We performed an electronic search of Ovid Medline, Embase and International Pharmaceutical Abstracts from 1966 to August 2010 for studies that measured adherence to cardiovascular medications in the developing world. A DerSimonian-Laird random effects method was used to pool the adherence estimates across studies. Between-study heterogeneity was estimated with an I2 statistic and studies were stratified by disease group and the method by which adherence was assessed. Predictors of non-adherence were also examined.
Our search identified 2,353 abstracts, of which 76 studies met our inclusion criteria. Overall adherence was 57.5% (95% confidence interval [CI] 52.3% to 62.7%; I2 0.98) and was consistent across study subgroups. Studies that assessed adherence with pill counts reported higher levels of adherence (62.1%, 95% CI 49.7% to 73.8%; I2 0.83) than those using self-report (54.6%, 95% CI 47.7% to 61.5%; I2 0.93). Adherence did not vary by geographic region, urban vs. rural settings, or the complexity of a patient’s medication regimen. The most common predictors of poor adherence included poor knowledge, negative perceptions about medication, side effects and high medication costs.
Our study indicates that adherence to cardiovascular medication in resource-limited countries is sub-optimal and appears very similar to that observed in resource-rich countries. Efforts to improve adherence in resource-limited settings should be a priority given the burden of heart disease in this context, the central role of medications in their management, and the clinical and economic consequences of non-adherence.
- WHO. Adherence to Long-term Therapies: Evidence for action. World Health Organisation 2003.
- Choudhry NK. Improving the pathway from cardiovascular medication prescribing to longer-term adherence: new results about old issues. Circ Cardiovasc Qual Outcomes. 2010;3:223–5. CrossRef
- Choudhry NK, Setoguchi S, Levin R, Winkelmayer WC, Shrank WH. Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients. Pharmacoepidemiol Drug Saf. 2008;17:1189–96. CrossRef
- Choudhry NK, Winkelmayer WC. Medication adherence after myocardial infarction: a long way left to go. J Gen Intern Med. 2008;23:216–8. CrossRef
- Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14:357–66. CrossRef
- Mills EJ, Nachega JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296:679–90. CrossRef
- International Monetary Fund. World economic and financial surveys: List of emerging and developing economies; 2009.
- Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses.
- West S, King V, Carey ST, et al. Systems to Rate the Strength Of Scientific Evidence: Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services; 2002 April 2002.
- Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1–12. CrossRef
- Jaynes ET. Confidence intervals vs. Bayesian intervals. In: Harper WL, Hooker CA, eds. Foundations of probability theory, statistical inference, and statistical theories of science. Dordrecht: Reidel; 1976.
- Stuart A, Ord JK. Kendall's Advanced Theory of Statistics. 6th ed. London: Arnold Publishers; 1994.
- DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88. CrossRef
- Fleiss JL. The statistical basis of meta-analysis. Stat Methods Med Res. 1993;2:121–45. CrossRef
- Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58. CrossRef
- Akpa MR, Agomuoh DI, Odia OJ. Drug compliance among hypertensive patients in Port Harcourt, Nigeria. Niger J Med. 2005;14:55–7.
- Almas A, Hameed A, Ahmed B, Islam M. Compliance to antihypertensive therapy. J Coll Physicians Surg Pak. 2006;16:23–6.
- Amira OC, Okubadejo NU. Frequency of complementary and alternative medicine utilization in hypertensive patients attending an urban tertiary care centre in Nigeria. BMC Complement Altern Med. 2007;7:30. CrossRef
- Ben Abdelaziz A, Ben Othman A, Mandhouj O, Gaha R, Bouabid Z, Ghannem H. [Audit of management of arterial hypertension in primary health care in Sousse]. Tunis Med. 2006;84:148–54.
- Bharucha NE, Kuruvilla T. Hypertension in the Parsi community of Bombay: a study on prevalence, awareness and compliance to treatment. BMC Public Health. 2003;3:1. CrossRef
- Bovet P, Burnier M, Madeleine G, Waeber B, Paccaud F. Monitoring one-year compliance to antihypertension medication in the Seychelles. Bull World Health Organ. 2002;80:33–9.
- Buabeng K. Unaffordable drug prices: the major cause of non-compliance with hypertension medication in Ghana. J Pharm Pharm Sci. 2004;7:350–2.
- Buchanan N, Shuenyane E, Mashigo S, Mtangai P, Unterhalter B. Factors influencing drug compliance in ambulatory Black urban patients. S Afr Med J. 1979;55:368–73.
- Castro RA, Moncau JE, Marcopito LF. Hypertension prevalence in the city of Formiga, MG, Brazil. Arq Bras Cardiol. 2007;88:334–9. CrossRef
- Chen W, Huang X, Zheng J, Huang W. Survey on drug compliance of patients with hypertension in residents at Shangmeilin new community in Shenzhen. Chin J Clin Rehabil. 2004;8:5790–1.
- Coelho EB. Moyses Neto M, Palhares R, Cardoso MC, Geleilete TJ, Nobre F. Relationship between regular attendance to ambulatory appointments and blood pressure control among hypertensive patients. Arq Bras Cardiol. 2005;85:157–61.
- de Souza WA, Yugar-Toledo JC, Bergsten-Mendes G, Sabha M, Moreno H Jr. Effect of pharmaceutical care on blood pressure control and health-related quality of life in patients with resistant hypertension. Am J Health Syst Pharm. 2007;64:1955–61. CrossRef
- Dennison CR, Peer N, Steyn K, Levitt NS, Hill MN. Determinants of hypertension care and control among peri-urban Black South Africans: the HiHi study. Ethn Dis. 2007;17:484–91.
- Elzubier AG, Husain AA, Suleiman IA, Hamid ZA. Drug compliance among hypertensive patients in Kassala, eastern Sudan. East Mediterr Health J. 2000;6:100–5.
- Feng L, Lui J, Duan Y. Medical order-obeying behavior in 164 patients with essential hypertension. Chin J Clin Rehabil. 2005;9:150–1.
- Fodor GJ, Kotrec M, Bacskai K, et al. Is interview a reliable method to verify the compliance with antihypertensive therapy? An international central-European study. J Hypertens. 2005;23:1261–6. CrossRef
- Hadi N, Rostami-Gooran N. Determinant factors of medication compliances in hypertensive patients of Shiraz, Iran. Archives of Iranian Medicine. 2004;7:292–6.
- Hassan NB, Hasanah CI, Foong K, et al. Identification of psychosocial factors of noncompliance in hypertensive patients. J Hum Hypertens. 2006;20:23–9. CrossRef
- Hungerbuhler P, Bovet P, Shamlaye C, Burnand B, Waeber B. Compliance with medication among outpatients with uncontrolled hypertension in the Seychelles. Bull World Health Organ. 1995;73:437–42.
- Joshi PP, Salkar RG, Heller RF. Determinants of poor blood pressure control in urban hypertensives of central India. J Hum Hypertens. 1996;10:299–303.
- Konin C, Adoh M, Coulibaly I, et al. Black Africans' compliance to antihypertensive treatment. Arch Mal Coeur Vaiss. 2007;100:630–4.
- Lambert EV, Steyn K, Stender S, Everage N, Fourie JM, Hill MN. Cross-cultural validation of the hill-bone compliance to high blood pressure therapy scale in a South African, primary healthcare setting. Ethn Dis. 2006;16:286–91.
- Li W, Jiang X, Ma H, et al. Awareness, treatment and control of hypertension in patients attending hospital clinics in China. J Hypertens. 2003;21:1191–7. CrossRef
- Lim TO, Ngah BA. The Mentakab Hypertension Study project. Part II–Why do hypertensives drop out of treatment? Singapore Med J. 1991;32:249–51.
- Lu J, Li LM, Cao WH, Zhan SY, Hu YH. Postmarketing surveillance on Benazepril. Zhonghua Liu Xing Bing Xue Za Zhi. 2004;25:412–6.
- Lunt DW, Edwards PR, Steyn K, Lombard CJ, Fehrsen GS. Hypertension care at a Cape Town community health centre. S Afr Med J. 1998;88:544–8.
- Maro EE, Lwakatare J. Medication compliance among Tanzanian hypertensives. East Afr Med J. 1997;74:539–42.
- Marshall RA, Yach D. Management of hypertension in Mamre women. S Afr Med J. 1988;74:346–8.
- Naddaf A. Lifestyle of hypertensive patients and their drug compliance. Bulletin of Pharmaceutical Sciences. 2004;27:307–14.
- Nugmanova A, Pillai G, Nugmanova D, Kuter D. Improving the management of hypertension in Kazakhstan: Implications for improving clinical practice, patient behaviors, and health outcomes. Global Public Health. 2008;3:214–31. CrossRef
- Peltzer K. Health beliefs and prescription medication compliance among diagnosed hypertension clinic attenders in a rural South African Hospital. Curationis. 2004;27:15–23.
- Qureshi NN, Hatcher J, Chaturvedi N, Jafar TH. Effect of general practitioner education on adherence to antihypertensive drugs: cluster randomised controlled trial. BMJ. 2007;335:1030. CrossRef
- Roy PK, Arif SM, Alam MR, Khan FD, Ahmad Q, Chowdhury SG. Stroke in patients having inadequate or irregular antihypertensive therapy. Bangladesh Med Res Counc Bull. 1990;16:52–7.
- Salako BL, Ajose FA, Lawani E. Blood pressure control in a population where antihypertensives are given free. East Afr Med J. 2003;80:529–31.
- Salome Kruger H, Gerber JJ. Health beliefs and compliance of black South African outpaitents with antihypertensive medication. Journal of Social and Administrative Pharmacy. 1998;15:201–9.
- Saunders LD, Irwig LM, Gear JS, Ramushu DL. A randomized controlled trial of compliance improving strategies in Soweto hypertensives. Med Care. 1991;29:669–78. CrossRef
- Sookaneknun P, Richards RM, Sanguansermsri J, Teerasut C. Pharmacist involvement in primary care improves hypertensive patient clinical outcomes. Ann Pharmacother. 2004;38:2023–8. CrossRef
- Stein CM, Neill P, Mwaluko GM, Kusema T. Combination of a thiazide, a vasodilator and reserpine compared with methyldopa plus hydrochlorothiazide in the treatment of hypertension in Zimbabwe. S Afr Med J. 1990;77:243–5.
- Supramaniam V. Study of Malaysian military hypertensives–therapy compliance. Med J Malaysia. 1982;37:249–52.
- Unterhalter B. Compliance with Western medical treatment in a group of black ambulatory hospital patients. Soc Sci Med [Med Psychol Med Sociol]. 1979;13A:621–30.
- Xiao H-M, Jiang X-Y. Drug compliance of elderly patients with hypertension. Chin J Clin Rehabil. 2005;9:30–1.
- Youssef RM, Moubarak II. Patterns and determinants of treatment compliance among hypertensive patients. East Mediterr Health J. 2002;8:579–92.
- Yusuff K, Alabi A. Assessing patient adherence to anti-hypertensive drug therapy: Can a structured pharmacist-conducted interview separated the wheat from the chaff? International Journal of Pharmacy Practice. 2007;15:295–300. CrossRef
- Yusuff KB, Balogun OB. Pattern of drug utilization among hypertensives in a Nigerian teaching hospital. Pharmacoepidemiol Drug Saf. 2005;14:69–74. CrossRef
- Zdrojewski T, Januszko W, Drygas W, et al. Pharmacotherapy of arterial hypertension and pharmacoeconomic aspects of hypotensive therapy in elderly patients in Poland. Pol Arch Med Wewn. 1999;102:787–95.
- Jiang X, Li W, Ma L, Kong L, Jin S, Liu L. Knowledge on hypertension and the effect of management on hypertension in patients attending hospital clinics. Zhonghua Liu Xing Bing Xue Za Zhi. 2002;23:269–72.
- Khalil SA, Elzubier AG. Drug compliance among hypertensive patients in Tabuk, Saudi Arabia. J Hypertens. 1997;15:561–5. CrossRef
- Toprak D, Demir S. Treatment choices of hypertensive patients in Turkey. Behav Med. 2007;33:5–10. CrossRef
- Prado JC Jr, Kupek E, Mion D Jr. Validity of four indirect methods to measure adherence in primary care hypertensives. J Hum Hypertens. 2007;21:579–84.
- Venter HL, Joubert PH, Foukaridis GN. Compliance in black patients with non-insulin-dependent diabetes mellitus receiving oral hypoglycaemic therapy. S Afr Med J. 1991;79:549–51.
- Babwah F, Baksh S, Blake L, et al. The role of gender in compliance and attendance at an outpatient clinic for type 2 diabetes mellitus in Trinidad. Rev Panam Salud Publica. 2006;19:79–84. CrossRef
- Cui J. Association of educational level and behavior of medical compliance with the level of blood glucose in diabetic patients. Chin J Clin Rehabil. 2005;2005:36.
- Duff EM, O'Connor A, McFarlane-Anderson N, Wint YB, Bailey EY, Wright-Pascoe RA. Self-care, compliance and glycaemic control in JAMAican adults with diabetes mellitus. West Indian Med J. 2006;55:232–6. CrossRef
- Duran-Varela BR, Rivera-Chavira B, Franco-Gallegos E. Pharmacological therapy compliance in diabetes. Salud Publica Mex. 2001;43:233–6. CrossRef
- El-Shazly M, Abdel-Fattah M, Zaki A, et al. Health care for diabetic patients in developing countries: a case from Egypt. Public Health. 2000;114:276–81. CrossRef
- Garay-Sevilla ME, Nava LE, Malacara JM, et al. Adherence to treatment and social support in patients with non-insulin dependent diabetes mellitus. J Diabetes Complications. 1995;9:81–6. CrossRef
- Hanko B, Kazmer M, Kumli P, et al. Self-reported medication and lifestyle adherence in Hungarian patients with Type 2 diabetes. Pharm World Sci. 2007;29:58–66. CrossRef
- Hernandez-Ronquillo L, Tellez-Zenteno JF, Garduno-Espinosa J, Gonzalez-Acevez E. Factors associated with therapy noncompliance in type-2 diabetes patients. Salud Publica Mex. 2003;45:191–7. CrossRef
- Kaur K, Singh MM, Kumar, Walia I. Knowledge and self-care practices of diabetics in a resettlement colony of Chandigarh. Indian J Med Sci. 1998;52:341–7.
- Khattab MS, Aboifotouh MA, Khan MY, Humaidi MA, al-Kaldi YM. Compliance and control of diabetes in a family practice setting, Saudi Arabia. East Mediterr Health J. 1999;5:755–65.
- Roaeid RB, Kablan AA. Profile of diabetes health care at Benghazi Diabetes Centre, Libyan Arab JAMAhiriya. East Mediterr Health J. 2007;13:168–76.
- Srinivas G, Suresh E, Jagadeesan M, Amalraj E, Datta M. Treatment-seeking behavior and compliance of diabetic patients in a rural area of south India. Ann N Y Acad Sci. 2002;958:420–4. CrossRef
- Yousuf M, Ali M, Bano I. Non-compliance of drug therapy in diabetics- Experience at Lahore. Pakistan Journal of Medical Sciences. 2001;17:74–8.
- Zhang CY, Xie S, Li Y, Li Z. Survey of the drug compliance of type 2 diabetic patients in Chenghai district of Shantou city. Chin J Clin Rehabil. 2005;9:14–5.
- Bhagat K, Mazayi-Mupanemunda M. Compliance with medication in patients with heart failure in Zimbabwe. East Afr Med J. 2001;78:45–8.
- Joshi PP, Mohanan CJ, Sengupta SP, Salkar RG. Factors precipitating congestive heart failure–role of patient non-compliance. J Assoc Physicians India. 1999;47:294–5.
- Sadik A, Yousif M, McElnay JC. Pharmaceutical care of patients with heart failure. Br J Clin Pharmacol. 2005;60:183–93. CrossRef
- Moodley I. Analysis of a medical aid administrator database for costs and utilisation of benefits by patients claiming for lipid-lowering agents. Cardiovasc J S Afr. 2006;17:140–5.
- Asefzadeh S, Asefzadeh M, Javadi H. Care management: Adherence to therapies among patients at Bu-Alicina Clinic, Qazvin, Iran. Journal of Research in Medical Sciences. 2005;10:343–8.
- Chizzola PR, Mansur AJ, da Luz PL, Bellotti G. Compliance with pharmacological treatment in outpatients from a Brazilian cardiology referral center. Sao Paulo Med J. 1996;114:1259–64. CrossRef
- Dantas RA, Aguillar OM, dos Santos Barbeira CB. Implementation of a nurse-monitored protocol in a Brazilian hospital: a pilot study with cardiac surgery patients. Patient Educ Couns. 2002;46:261–6. CrossRef
- El-Gatit AM, Haw M. Relationship between depression and non-adherence to anticoagulant therapy after valve replacement. East Mediterr Health J. 2003;9:12–9.
- Kocer A, Ince N, Kocer E, Tasci A. Factors influencing treatment compliance among Turkish people at risk for stroke. J Prim Prev. 2006;27:81–9. CrossRef
- Olubodun JO, Falase AO, Cole TO. Drug compliance in hypertensive Nigerians with and without heart failure. Int J Cardiol. 1990;27:229–34. CrossRef
- Rotchford AP, Rotchford KM. Diabetes in rural South Africa–an assessment of care and complications. S Afr Med J. 2002;92:536–41.
- Wiseman IC, Miller R. Quantifying non-compliance in patients receiving digoxin–a pharmacokinetic approach. S Afr Med J. 1991;79:155–7.
- Di Matteo M. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42:200–9. CrossRef
- Chan DC, Shrank WH, Cutler D, et al. Patient, physician, and payment predictors of statin adherence. Med Care. 2010;48:196–202. CrossRef
- Gaziano, T. Cardiovascular disease in the developing world and its cost-effective management. Circulation. 2005;112:3547–53. CrossRef
- Woolf SH, Johnson RE. The break-even point: when medical advances are less important than improving the fidelity with which they are delivered. Ann Fam Med. 2005;3:545–52. CrossRef
- Green CA. What can patient health education coordinators learn from ten years of compliance research? Patient Education & Counseling. 1987;10:167–74. CrossRef
- Kesselheim AS, Choudhry NK. The international pharmaceutical market as a source of low-cost prescription drugs for U.S. patients. Ann Intern Med. 2008;148:614–9.
- Mills EJ, Nachega JB, Bangsberg D, et al. Adherence to HAART: A Systematic Review of Developed and Developing Nation Patient-reported Barriers and Facilitators. PLoS Med. 2006;3:e438. CrossRef
- Choudhry NK, Fischer MA, Avorn J, et al. The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med. 2011;171:814–22. CrossRef
- Choudhry NK. Promoting persistence: improving adherence through choice of drug class. Circulation. 2011;123:1584–6. CrossRef
- A Systematic Review of Adherence to Cardiovascular Medications in Resource-Limited Settings
Journal of General Internal Medicine
Volume 26, Issue 12 , pp 1479-1491
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- cardiovascular medications
- cardiovascular disease
- cardiovascular risk reduction
- Industry Sectors
- Author Affiliations
- 1. Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA, 02120, USA
- 2. Department of Family and Community Medicine, St. Michael’s Hospital, University of Toronto, Toronto, Canada